Oxysterols Receptor LXR-Beta (NR1H2) Antibody

Este producto es parte de NR1H - nuclear receptor subfamily 1 group H member
Product Graph
351€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Oxysterols Receptor LXR-Beta (NR1H2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx375969
tested applications
ELISA, WB

Description

Oxysterols Receptor LXR-Beta (NR1H2) Antibody is a Rabbit Polyclonal antibody against Oxysterols Receptor LXR-Beta (NR1H2).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryPrimary Antibodies
Immunogen TargetOxysterols Receptor LXR-Beta (NR1H2)
HostRabbit
ReactivityHuman, Mouse, Rat
Recommended DilutionOptimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
ConjugationUnconjugated
PurificationPurified by affinity chromatography using epitope-specific immunogen.
Size 1100 µg
FormLiquid
Tested ApplicationsELISA, WB
BufferPBS, pH 7.4, containing 0.02% sodium azide and 50% glycerol.
AvailabilityShipped within 5-12 working days.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry IceNo
UniProt IDP55055
Gene ID7376
AliasNER,UNR,LXRB,LXR-b,NER-I,RIP15,Oxysterols receptor LXR-beta,Liver X receptor beta,Nuclear receptor NER
BackgroundAntibody anti-NR1H2
StatusRUO
NoteConcentration: 1 mg/ml -

Descripción

Nuclear receptor subfamily 1 group H member 2 (NR1H2), also known as LXRα (liver X receptor alpha), is a nuclear receptor involved in regulating lipid metabolism, cholesterol homeostasis, and immune response NR1H2 is primarily expressed in tissues such as the liver, adipose tissue, and macrophages, where it regulates genes involved in the absorption, storage, and catabolism of cholesterol and lipids LXRα plays a key role in maintaining cholesterol balance by promoting the expression of genes that enhance cholesterol efflux and inhibit cholesterol biosynthesis It also regulates inflammatory pathways, influencing the immune system's response to atherosclerosis and other chronic inflammatory diseases Dysregulation of NR1H2 signaling has been associated with cardiovascular diseases, such as atherosclerosis, where improper lipid metabolism leads to the accumulation of cholesterol plaques in blood vessels LXRα is also a potential therapeutic target for managing metabolic diseases, inflammation, and lipid-related disorders

Related Products

EH0774

Human NR1H2(Oxysterols receptor LXR-beta) ELISA Kit

Ver Producto
FNab05834

anti- NR1H2 antibody

Nuclear receptor. Binds preferentially to double-stranded oligonucleotide direct repeats having the consensus half-site sequence 5'-AGGTCA-3' and 4-nt spacing(DR-4). Regulates cholesterol uptake through MYLIP-dependent ubiquitination of LDLR, VLDLR and LRP8; DLDLR and LRP8. Interplays functionally with RORA for the regulation of genes involved in liver metabolism(By similarity). Exhibits a ligand-dependent transcriptional activation activity(PubMed:25661920).

Ver Producto
abx033981

Oxysterols Receptor LXR-Beta (NR1H2) Antibody

The liver X receptors, LXRA (NR1H3; MIM 602423) and LXRB, form a subfamily of the nuclear receptor superfamily and are key regulators of macrophage function, controlling transcriptional programs involved in lipid homeostasis and inflammation.

Ver Producto